69 related articles for article (PubMed ID: 17999162)
1. Beyond nC60: strategies for identification of transformation products of fullerene oxidation in aquatic and biological samples.
Pycke BF; Chao TC; Herckes P; Westerhoff P; Halden RU
Anal Bioanal Chem; 2012 Nov; 404(9):2583-95. PubMed ID: 22644149
[TBL] [Abstract][Full Text] [Related]
2. Chloroquine-mediated lysosomal dysfunction enhances the anticancer effect of nutrient deprivation.
Harhaji-Trajkovic L; Arsikin K; Kravic-Stevovic T; Petricevic S; Tovilovic G; Pantovic A; Zogovic N; Ristic B; Janjetovic K; Bumbasirevic V; Trajkovic V
Pharm Res; 2012 Aug; 29(8):2249-63. PubMed ID: 22538436
[TBL] [Abstract][Full Text] [Related]
3. Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics.
Meng J; Wang DL; Wang PC; Jia L; Chen C; Liang XJ
J Nanosci Nanotechnol; 2010 Dec; 10(12):8610-6. PubMed ID: 21121373
[TBL] [Abstract][Full Text] [Related]
4. Quantitative nanostructure-activity relationship modeling.
Fourches D; Pu D; Tassa C; Weissleder R; Shaw SY; Mumper RJ; Tropsha A
ACS Nano; 2010 Oct; 4(10):5703-12. PubMed ID: 20857979
[TBL] [Abstract][Full Text] [Related]
5. Modulation of tumor necrosis factor-mediated cell death by fullerenes.
Harhaji L; Isakovic A; Vucicevic L; Janjetovic K; Misirkic M; Markovic Z; Todorovic-Markovic B; Nikolic N; Vranjes-Djuric S; Nikolic Z; Trajkovic V
Pharm Res; 2008 Jun; 25(6):1365-76. PubMed ID: 17999162
[TBL] [Abstract][Full Text] [Related]
6. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene.
Isakovic A; Markovic Z; Todorovic-Markovic B; Nikolic N; Vranjes-Djuric S; Mirkovic M; Dramicanin M; Harhaji L; Raicevic N; Nikolic Z; Trajkovic V
Toxicol Sci; 2006 May; 91(1):173-83. PubMed ID: 16476688
[TBL] [Abstract][Full Text] [Related]
7. Hydroxylated fullerene: a potential antiinflammatory and antioxidant agent for preventing mouse preterm birth.
Wakimoto T; Uchida K; Mimura K; Kanagawa T; Mehandjiev TR; Aoshima H; Kokubo K; Mitsuda N; Yoshioka Y; Tsutsumi Y; Kimura T; Yanagihara I
Am J Obstet Gynecol; 2015 Nov; 213(5):708.e1-9. PubMed ID: 26196453
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity and TNF-alpha secretion in RAW264.7 macrophages exposed to different fullerene derivatives.
Xiang K; Dou Z; Li Y; Xu Y; Zhu J; Yang S; Sun H; Liu Y
J Nanosci Nanotechnol; 2012 Mar; 12(3):2169-78. PubMed ID: 22755034
[TBL] [Abstract][Full Text] [Related]
9. Disruption of redox homeostasis in tumor necrosis factor-induced apoptosis in a murine hepatocyte cell line.
Pierce RH; Campbell JS; Stephenson AB; Franklin CC; Chaisson M; Poot M; Kavanagh TJ; Rabinovitch PS; Fausto N
Am J Pathol; 2000 Jul; 157(1):221-36. PubMed ID: 10880392
[TBL] [Abstract][Full Text] [Related]
10. Beta-actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell death.
Li J; Li Q; Xie C; Zhou H; Wang Y; Zhang N; Shao H; Chan SC; Peng X; Lin SC; Han J
J Cell Sci; 2004 Sep; 117(Pt 20):4673-80. PubMed ID: 15371523
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of cell-damaging reactive oxygen generation by colloidal fullerenes.
Markovic Z; Todorovic-Markovic B; Kleut D; Nikolic N; Vranjes-Djuric S; Misirkic M; Vucicevic L; Janjetovic K; Isakovic A; Harhaji L; Babic-Stojic B; Dramicanin M; Trajkovic V
Biomaterials; 2007 Dec; 28(36):5437-48. PubMed ID: 17884160
[TBL] [Abstract][Full Text] [Related]
12. Towards the development of tumor necrosis factor (TNF) sensitizers: making TNF work against cancer.
Mocellin S; Pilati P; Nitti D
Curr Pharm Des; 2007; 13(5):537-51. PubMed ID: 17348848
[TBL] [Abstract][Full Text] [Related]
13. Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA.
Berndtsson M; Hägg M; Panaretakis T; Havelka AM; Shoshan MC; Linder S
Int J Cancer; 2007 Jan; 120(1):175-80. PubMed ID: 17044026
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
